Laffer Tengler Investments Genmab A/S Transaction History

Laffer Tengler Investments

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $9,088 - $10,434	-243 Reduced 10.96%	1,974 $75 Million
Q1 2023 May 09, 2023	SELL	$34.88 - $43.22 $837 - $1,037	-24 Reduced 1.07%	2,217 $83.7 Million
Q4 2022 Feb 10, 2023	SELL	$33.8 - $47.06 $1,081 - $1,505	-32 Reduced 1.41%	2,241 $95 Million
Q3 2022 Nov 10, 2022	SELL	$31.52 - $373.61 $788 - $9,340	-25 Reduced 1.09%	2,273 $73 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $76,063 - $109,345	-2,835 Reduced 55.23%	2,298 $74.7 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $63,602 - $81,542	-2,055 Reduced 28.59%	5,133 $186 Million
Q4 2021 Feb 11, 2022	SELL	$35.87 - $47.12 $10,545 - $13,853	-294 Reduced 3.93%	7,188 $284 Million
Q3 2021 Nov 16, 2021	BUY	$41.55 - $48.72 $70,967 - $83,213	1,708 Added 29.58%	7,482 $327 Million
Q2 2021 Aug 16, 2021	BUY	$32.88 - $44.57 $13,743 - $18,630	418 Added 7.8%	5,774 $236 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $45,081 - $64,735	1,458 Added 37.4%	5,356 $176 Million
Q4 2020 Jun 11, 2021	BUY	$33.66 - $40.76 $131,206 - $158,882	3,898 New	3,898 $159 Million
Q4 2020 Feb 19, 2021	SELL	$33.66 - $40.76 $101,080 - $122,402	-3,003 Closed	0 $0
Q2 2020 Jun 11, 2021	BUY	$20.05 - $33.89 $60,210 - $101,771	3,003 New	3,003 $102 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Laffer Tengler Investments, based on Form 13F filings with the SEC.

Stay updated on Laffer Tengler Investments with notifications on news.